Global Endometriosis Treatment Market Size study, By Drug Type {Oral Contraceptives Progestins, NSAIDs, GnRH Analogues, LNR-IUDs, Others}, By Treatment Type {Hormonal Therapy, Pain Management}, By End-use{Hospital Pharmacies, Retail Pharmacies, Drug stores, e-Commerce}, Analysis Regional Forecasts 2021-2027
- BIZ4639323
- 200 Pages
- September 2021
- Pharmaceuticals
When tissues that make up the lining of the uterus, grow outside of it, the disorder is called endometriosis. In Endometriosis, women face pain in the lower abdomen, cramps, and sometimes a high flow of blood. Endometriosis is divided into stages between level 1 (minimum or starting stage) to level 4 (severe or extreme stage). The established player has odds in their favor to lead the market and also expand their business portfolio by launching higher efficient and well-tested drugs into the market. One of the major trends that are driving this market is the awareness among women health and safety and governments investing into better treatment facilities and upgraded technologies used to reduce these diseases. Patient assistance programs are also spreading widely among various regions. However, limited availability of diagnostics is a major factor affecting this market negatively, but diagnostic facilities are expected to increase in the future. The ultrasound market is going to cover the largest market share, due to the upgradation in the technology and growing demand for diagnostic procedures. In 2018, Astellas Pharma announced the manufacturing of Opigolix drug that will be used for oral treatment of endometriosis.
The key regions covered in the global Endometriosis Treatment market are North America, Latin America, Europe, East Asia, South Asia-Pacific, and the Middle East & Africa. North America holds the largest market share, because of growing awareness about endometriosis treatment and the rate of incidences growing rapidly in that region. Due to higher population, growing market, and a large number of market players being present in the market, the Asia Pacific region is expected to grow in the future.
Major market players included in this report are:
Abbott Laboratories
AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bayer AG
Eli Lilly and Company
Ipsen
Meditrina Pharmaceuticals Private Limited
Myovant Sciences Ltd
Neurocrine Biosciences Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Oral Contraceptives
Progestins
NSAIDs
GnRH Analogues
LNR-IUDs
Others
By Treatment Type:
Hormonal Therapy
Pain Management
By End-use:
Hospital Pharmacies
Retail Pharmacies
Drugstores
e-Commerce
By Region:
North America
The U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Endometriosis Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Endometriosis Treatment Market, by Drug Type, 2019-2027 (USD Billion)
1.2.2. Endometriosis Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
1.2.3. Endometriosis Treatment Market, by End-use, 2019-2027 (USD Billion)
1.2.4. Global Endometriosis Treatment Market, by region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Endometriosis Treatment Market Definition and Scope
2.1. The objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Endometriosis Treatment Market Dynamics
3.1. Global Endometriosis Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing awareness about women health and safety
3.1.1.2. The surge in demand for patient assistance program
3.1.2. Market Challenges
3.1.2.1. Limited availability of diagnostics
3.1.3. Market Opportunities
3.1.3.1. Vertical business development (product expansions)
Chapter 4. Global Endometriosis Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. The threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Endometriosis Treatment Market by Drug Type
5.1. Market Snapshot
5.2. Global Endometriosis Treatment Market by Drug Type, Performance - Potential Analysis
5.3. Global Endometriosis Treatment Market estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
5.4. Endometriosis Treatment Market, Sub Segment Analysis
5.4.1. Oral Contraceptives
5.4.2. Progestins
5.4.3. NSAIDs
5.4.4. GnRH Analogues
5.4.5. LNR-IUDs
5.4.6. Others
Chapter 6. Global Endometriosis Treatment Market by Treatment Type
6.1. Market Snapshot
6.2. Global Endometriosis Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Endometriosis Treatment Market estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
6.4. Endometriosis Treatment Market, Sub Segment Analysis
6.4.1. Hormonal Therapy
6.4.2. Pain Management
Chapter 7. Global Endometriosis Treatment Market by End-use
7.1. Market Snapshot
7.2. Global Endometriosis Treatment Market by End-use, Performance - Potential Analysis
7.3. Global Endometriosis Treatment Market estimates & Forecasts by End-use 2018-2027 (USD Billion)
7.4. Endometriosis Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Drugstores
7.4.4. e-Commerce
Chapter 8. Global Endometriosis Treatment Market, Regional Analysis
8.1. Global Endometriosis Treatment Market, Regional Market Snapshot
8.2. North America Endometriosis Treatment Market
8.2.1. U.S. Endometriosis Treatment Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Endometriosis Treatment Market
8.3. Europe Endometriosis Treatment Market Snapshot
8.3.1. The U.K. Endometriosis Treatment Market
8.3.2. Germany Endometriosis Treatment Market
8.3.3. France Endometriosis Treatment Market
8.3.4. Spain Endometriosis Treatment Market
8.3.5. Italy Endometriosis Treatment Market
8.3.6. Rest of Europe Endometriosis Treatment Market
8.4. Asia-Pacific Endometriosis Treatment Market Snapshot
8.4.1. China Endometriosis Treatment Market
8.4.2. India Endometriosis Treatment Market
8.4.3. Japan Endometriosis Treatment Market
8.4.4. Australia Endometriosis Treatment Market
8.4.5. South Korea Endometriosis Treatment Market
8.4.6. Rest of Asia Pacific Endometriosis Treatment Market
8.5. Latin America Endometriosis Treatment Market Snapshot
8.5.1. Brazil Endometriosis Treatment Market
8.5.2. Mexico Endometriosis Treatment Market
8.6. Rest of The World Endometriosis Treatment Market
Chapter 9. Competitive Intelligence
9.1.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AbbVie Inc.
9.2.3. Astellas Pharma Inc.
9.2.4. AstraZeneca PLC
9.2.5. Bayer AG
9.2.6. Eli Lilly and Company
9.2.7. Ipsen
9.2.8. Meditrina Pharmaceuticals Private Limited
9.2.9. Myovant Sciences Ltd
9.2.10. Neurocrine Biosciences Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 1. Global Endometriosis Treatment Market, report scope
TABLE 2. Global Endometriosis Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Endometriosis Treatment Market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
TABLE 4. Global Endometriosis Treatment Market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)
TABLE 5. Global Endometriosis Treatment Market estimates & forecasts by End-use 2018-2027 (USD Billion)
TABLE 6. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of Endometriosis Treatment Market
TABLE 56. List of primary sources, used in the study of Endometriosis Treatment Market
TABLE 57. Years Considered for the study
TABLE 58. Exchange rates considered
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
